369 results on '"Reis-Filho, J. S."'
Search Results
2. The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
3. Mechanism of action of a WWTR1(TAZ)-CAMTA1 fusion oncoprotein
4. Response to dual HER2 blockade in a patient with HER3-mutant metastatic breast cancer
5. Identification of novel determinants of resistance to lapatinib in ERBB2-amplified cancers
6. Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies
7. Dysregulated TRK signalling is a therapeutic target in CYLD defective tumours
8. Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome
9. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
10. Integrative molecular profiling of triple negative breast cancers identifies amplicon drivers and potential therapeutic targets
11. A validated gene expression profile for detecting clinical outcome in breast cancer using artificial neural networks
12. Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA: a proof-of-principle
13. BRCA1 dysfunction in sporadic basal-like breast cancer
14. Basal-like breast cancer and the BRCA1 phenotype
15. Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer
16. Effect of HER2 on prognosis and benefit from peri-operative chemotherapy in early oesophago-gastric adenocarcinoma in the MAGIC trial
17. Molecular subclasses of breast cancer: how do we define them? The IMPAKT 2012 Working Group Statement†
18. Genomic analyses to select patients for adjuvant chemotherapy: trials and tribulations
19. ORIGINAL ARTICLE: Endoglin expression in breast tumor cells suppresses invasion and metastasis and correlates with improved clinical outcome
20. Genomic profile of a secretory breast cancer with an ETV6–NTRK3 duplication
21. Breast cancer special types: why bother?#
22. The genomic profile of HER2-amplified breast cancers: the influence of ER status#
23. ESR1 amplification in endometrial carcinomas: hope or hyperbole?#
24. Hereditary breast cancer: from molecular pathology to tailored therapies
25. Nestin is expressed in basal-like and triple negative breast cancers
26. Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas
27. Genomic and immunophenotypical characterization of pure micropapillary carcinomas of the breast#
28. Is acinic cell carcinoma a variant of secretory carcinoma? A FISH study using ETV6‘split apart’ probes
29. Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype
30. Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis
31. Complex patterns of chromosome 9 alterations including the p16INK4a locus in Wilms tumours
32. Triple negative tumours: a critical review
33. Expression profiling technology: its contribution to our understanding of breast cancer
34. Homologous recombination DNA repair defects in PALB2-associated breast cancers
35. Non-operative breast pathology: columnar cell lesions
36. The expression of Wilmsʼ tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast
37. Basal-like carcinomas: from pathology to mouse-models and beyond
38. Molecular Genetic Analysis of Ovarian Clear Cell Adenocarcinomas Reveals Novel Pathobiological Insights
39. Invasive micropapillary carcinomas of the breast: an immunohistochemical and chromogenic in situ hybridisation analysis
40. Microarray CGH analysis of invasive micropapillary carcinomas of the breast
41. Distribution and significance of Caveolin 2 expression in normal breast and breast cancer: an immunofluorescence and immunohistochemical analysis
42. BAC to INFINIUM: a comparison of near-tiling path BAC arrays and illumina HAP300 SNP arrays for molecular genetic profiling of breast cancer
43. Near tiling microarray-based CGH identifies CCNE1 amplification in basal-like breast cancer
44. Identification of transmembrane proteins as potential prognostic markers and therapeutic targets in breast cancer by a screen for signal sequence encoding transcripts
45. Molecular genetic analysis suggests a developmental origin for malignant myoepithelial carcinomas of the salivary gland from pleomorphic adenomas
46. EGFR amplification and lack of activating mutations in metaplastic breast carcinomas
47. BRCA1 gene promoter methylation in metaplastic breast carcinomas
48. Cyclin D1 protein overexpression and gene amplification in breast carcinomas: an immunohistochemical and CISH analysis
49. Comprehensive molecular genetic analysis reveals FGFR1 as a potential therapeutic target for lobular breast carcinomas
50. Metaplastic breast carcinomas are basal-like tumours
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.